Advertisement
Screener

Achieve Life Sciences, Inc. (ACHV) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

1.0 / 5 stars · 8/40 Roast Me

Achieve Life Sciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-12-31 was 0.00 shares.
  • Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-09-30 was 0.00 shares.
  • Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-06-30 was 0.00 shares.
  • Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-03-31 was 0.00 shares.
  • Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 0.00 shares.
  • Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 0.00 shares.
  • Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 0.00 shares.
  • Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 0.00 shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month
2025-12-310.00 shares
10-K · filed 2026-03-24
2024-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
0.00 shares
10-K · filed 2025-03-11
2024-09-300.00 shares
10-Q · filed 2024-11-07
0.00 shares
derived: sum of 4 quarters · filed 2026-03-24
2024-06-300.00 shares
10-Q · filed 2024-08-13
0.00 shares
derived: sum of 4 quarters · filed 2026-03-24
2024-03-310.00 shares
10-Q · filed 2024-05-09
0.00 shares
derived: sum of 4 quarters · filed 2026-03-24
2023-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24
0.00 shares
10-K · filed 2026-03-24
2023-09-300.00 shares
10-Q · filed 2024-11-07
0.00 shares
derived: sum of 4 quarters · filed 2024-11-07
2023-06-300.00 shares
10-Q · filed 2024-08-13
0.00 shares
derived: sum of 4 quarters · filed 2024-08-13
2023-03-310.00 shares
10-Q · filed 2024-05-09
0.00 shares
derived: sum of 4 quarters · filed 2024-05-09
2022-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
0.00 shares
10-K · filed 2024-03-28
2022-09-300.00 shares
10-Q · filed 2023-11-09
0.00 shares
derived: sum of 4 quarters · filed 2023-11-09
2022-06-300.00 shares
10-Q · filed 2023-08-14
0.00 shares
derived: sum of 4 quarters · filed 2023-08-14
2022-03-310.00 shares
10-Q · filed 2023-05-09
0.00 shares
derived: sum of 4 quarters · filed 2023-05-09
2021-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
0.00 shares
10-K · filed 2023-03-16
2021-09-300.00 shares
10-Q · filed 2022-11-14
0.00 shares
derived: sum of 4 quarters · filed 2022-11-14
2021-06-300.00 shares
10-Q · filed 2022-08-11
0.00 shares
derived: sum of 4 quarters · filed 2022-08-11
2021-03-310.00 shares
10-Q · filed 2022-05-12
0.00 shares
derived: sum of 4 quarters · filed 2022-05-12
2020-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
0.00 shares
10-K · filed 2022-03-10
2020-09-300.00 shares
10-Q · filed 2021-11-09
0.00 shares
derived: sum of 4 quarters · filed 2021-11-09
2020-06-300.00 shares
10-Q · filed 2021-08-12
0.00 shares
derived: sum of 4 quarters · filed 2021-08-12
2020-03-310.00 shares
10-Q · filed 2021-05-13
0.00 shares
derived: sum of 4 quarters · filed 2021-05-13
2019-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11
0.00 shares
10-K · filed 2021-03-11
2019-09-300.00 shares
10-Q · filed 2020-11-12
0.00 shares
derived: sum of 4 quarters · filed 2020-11-12
2019-06-300.00 shares
10-Q · filed 2020-08-06
0.00 shares
derived: sum of 4 quarters · filed 2020-08-06
2019-03-310.00 shares
10-Q · filed 2020-05-14
0.00 shares
derived: sum of 4 quarters · filed 2020-05-14
2018-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
0.00 shares
10-K · filed 2020-03-13
2018-09-300.00 shares
10-Q · filed 2019-11-06
0.00 shares
derived: sum of 4 quarters · filed 2019-11-06
2018-06-300.00 shares
10-Q · filed 2019-08-08
0.00 shares
derived: sum of 4 quarters · filed 2019-08-08
2018-03-310.00 shares
10-Q · filed 2019-05-15
0.00 shares
derived: sum of 4 quarters · filed 2019-05-15
2017-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14
0.00 shares
10-K · filed 2019-03-14
2017-09-300.00 shares
10-Q · filed 2018-11-07
0.00 shares
derived: sum of 4 quarters · filed 2018-11-07
2017-06-300.00 shares
10-Q · filed 2018-08-08
0.00 shares
derived: sum of 4 quarters · filed 2018-08-08
2017-03-310.00 shares
10-Q · filed 2018-05-09
0.00 shares
derived: sum of 4 quarters · filed 2018-05-09
2016-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
0.00 shares
10-K · filed 2018-03-01
2016-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
5.36K shares
derived: sum of 4 quarters · filed 2017-11-09
2016-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31
5.36K shares
derived: sum of 4 quarters · filed 2017-07-31
2016-03-310.00 shares
10-Q · filed 2017-05-15
5.36K shares
derived: sum of 4 quarters · filed 2017-05-15
2015-12-315.36K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
5.36K shares
10-K · filed 2017-02-23
2015-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
0.00 shares
derived: sum of 4 quarters · filed 2017-02-23
2015-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
0.00 shares
derived: sum of 4 quarters · filed 2017-02-23
2015-03-310.00 shares
10-Q · filed 2016-05-12
0.00 shares
derived: sum of 4 quarters · filed 2017-02-23
2014-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
10.00K shares
10-K · filed 2017-02-23
2014-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
10.00K shares
derived: sum of 4 quarters · filed 2016-03-09
2014-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13
10.00K shares
derived: sum of 4 quarters · filed 2016-03-09
2014-03-3110.00K shares
10-Q · filed 2015-05-14
10.38K shares
derived: sum of 4 quarters · filed 2016-03-09
2013-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09
3.48K shares
10-K · filed 2016-03-09
2013-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30
3.99K shares
derived: sum of 4 quarters · filed 2015-03-26
2013-06-30375.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
86.88K shares
derived: sum of 4 quarters · filed 2015-03-26
2013-03-313.10K shares
10-Q · filed 2014-04-30
120.75K shares
derived: sum of 4 quarters · filed 2015-03-26
2012-12-31513.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26
117.35K shares
10-K · filed 2015-03-26
2012-09-3082.90K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07
2012-06-3034.24K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08
2012-03-31-300.00 shares
10-Q · filed 2013-05-02
2011-12-3156.23K shares
10-K · filed 2014-03-11
2010-12-31194.96K shares
10-K · filed 2013-03-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92